Back
Entrada Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
65
TRDA
Entrada Therapeutics
Last Price:
18.85
Seasonality Move:
-34.62%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Entrada Therapeutics Price Quote
$18.85
+0.05 (+4.43%)
(Updated: November 23, 2024 at 5:57 AM ET)
Entrada Therapeutics Key Stats
Buy
65
Entrada Therapeutics (TRDA)
is a Buy
Day range:
$17.90 - $18.95
52-week range:
$10.95 - $20.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.15
P/B ratio:
1.67%
Volume:
95.9K
Avg. volume:
120.5K
1-year change:
65.49%
Market cap:
$703.5M
Revenue:
$129M
EPS:
$1.59
How Much Does Entrada Therapeutics Make?
-
How Much Are Entrada Therapeutics's Sales Annually?
TRDA Revenues are $129M -
How Much Profit Does Entrada Therapeutics's Make A Year?
TRDA net income is -$6.7M
Is Entrada Therapeutics Growing As A Company?
-
What Is Entrada Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.55% -
What Is Entrada Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Entrada Therapeutics Stock Price Performance
-
Did Entrada Therapeutics Stock Go Up Last Month?
Entrada Therapeutics share price went up by 9.75% last month -
Did TRDA's Share Price Rise Over The Last Year?
TRDA share price rose by 65.49% over the past 1 year
What Is Entrada Therapeutics 52-Week High & Low?
-
What Is Entrada Therapeutics’s 52-Week High Share Price?
Entrada Therapeutics has traded as high as $20.49 over the past 52 weeks -
What Is Entrada Therapeutics’s 52-Week Low Share Price?
Entrada Therapeutics has traded as low as $10.95 over the past 52 weeks
Entrada Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Entrada Therapeutics?
-
How Much Debt Does Entrada Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Entrada Therapeutics Have?
Cash and short term investments quarterly total is $449.3M -
What Is Entrada Therapeutics’s Book Value Per Share?
Book value per share is 11.30
Is Entrada Therapeutics Cash Flow Positive?
-
What Is TRDA Cash Flow From Operations?
Cash flow from operations (TTM) is -$14M -
What Is Entrada Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $102.3M -
What Is Entrada Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$62.1M
Entrada Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TRDA return on invested capital is 17.06% -
What Is Entrada Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 10.56% -
What Is TRDA Return On Equity?
ROE is a measure of profitability and is 17.06%
Entrada Therapeutics Earnings Date & Stock Price
-
What Is Entrada Therapeutics's Stock Price Today?
A single share of TRDA can be purchased today for 18.80 -
What Is Entrada Therapeutics’s Stock Symbol?
Entrada Therapeutics trades on the nasdaq under the ticker symbol: TRDA -
When Is Entrada Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Entrada Therapeutics is scheduled on March 13, 2025 -
When Is TRDA's next ex-dividend date?
Entrada Therapeutics's next ex-dividend date is November 24, 2024 -
How To Buy Entrada Therapeutics Stock?
You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Entrada Therapeutics Competitors
-
Who Are Entrada Therapeutics's Competitors?
Below is a list of companies who compete with Entrada Therapeutics or are related in some way:
Entrada Therapeutics Dividend Yield
-
What Is TRDA Dividend Yield?
Entrada Therapeutics’s dividend yield currently is 0% -
What Is Entrada Therapeutics’s Payout Ratio?
Entrada Therapeutics’s payout ratio is 0% -
When Did Entrada Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is Entrada Therapeutics’s Dividend Per Share?
Entrada Therapeutics pays a dividend of $0.00 per share
Entrada Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 44% |
| Revenue: | -55.25% | 64.8% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 25.57 |
| Upside from Last Price: | 36.01% |